Search Results

Showing results 1 - 10 of 289.
Sort By: Date ▼

Sperm donors have been promised anonymity for a century. Then came 23andMe.

September 16, 2019


Sperm banks have long promised donors that they can donate anonymously—but the rise of consumer genetic testing has made it difficult for clinics to make such a guarantee.

CRISPR shown to be safe to target HIV (but unsuccessful so far)

September 13, 2019


A patient with HIV/AIDS who received transplanted stem cells edited with CRISPR to have a mutation that blocks HIV is living without side effects, providing evidence that the gene-editing technology can safely target HIV, according to a case study published Wednesday in the New England Journal of Medicine.

In the states: Florida provider pays $85K to settle alleged HIPAA violation, New York to require warnings in vape stores, and more

September 13, 2019


American Health Line rounds up the latest health care news in the states.

Google to ban ads for unproven cell, gene, and stem cell therapies

September 10, 2019


Google on Friday announced a new policy banning advertisements for "unproven or experimental medical techniques," including most cellular, gene, and stem cell therapies.

How insurers are moving to cover multimillion-dollar gene therapies

September 9, 2019


Major insurers are eyeing and developing new strategies to help employers cover the cost of gene therapies priced at millions of dollars per treatment.

One family's $6M drug claim (and what it means for the future of rare diseases)

August 28, 2019


Dawn Patterson and two of her children have a rare bone disease, and the only treatment is a drug that was slated to cost $6 million a year—a high price tag that observers say is indicative of the pharmaceutical industry's growing interest in treatment for rare diseases.

The 16 health care companies 'changing the world,' according to Fortune

August 26, 2019


Fortune last week released its fifth annual Change the World list, which recognizes for-profit companies that are "doing well by doing good," and 16 health care companies made the list.

FDA approves Roche's cancer drug for personalized treatment

August 21, 2019


FDA on Thursday approved Roche's cancer drug designed to target a tumor's genetic driver rather than the tissue where the tumor originated.

'A very big deal': New study will use CRISPR to treat sickle cell disease

August 9, 2019


Doctors are testing whether they can use CRISPR to treat patients with sickle cell disease, marking the first time doctors in the United States have used the gene-editing tool to treat a patient with a genetic disorder.

CMS releases national coverage policy for CAR T-cell therapies

August 8, 2019


CMS on Wednesday announced that Medicare will cover FDA-approved CAR T-cell therapies nationwide at health care facilities that meet certain requirements, but the agency did not change Medicare's payment rates for the treatments.

Results Page: [Previous] 1 2 3 4 5  ... [Next]